Published August 5, 2021
| Version v1
Figure
Open
Valproic Acid Synergizes With Cisplatin and Cetuximab in vitro and in vivo in Head and Neck Cancer by Targeting the Mechanisms of Resistance - Unpublished data
- 1. Experimental Pharmacology Unit, Istituto Nazionale Tumori IRCCS "Fondazione G. Pascale", Naples, Italy
Description
Antitumor effects of valproic acid (VPA) in combination with Cisplatin/Cetuximab doublet in head and neck squamous cell carcinoma (HNSCC) models. We reported unpublished data of the effects of this combination on cell cycle and 3D cell cultures
Files
Iannelli et al 3D colture.pdf
Files
(1.1 MB)
| Name | Size | Download all |
|---|---|---|
|
md5:b78031bbe5dbcb9e86fa7b35833bb93d
|
516.8 kB | Preview Download |
|
md5:fac43f8b84350eee52845969729feac8
|
565.6 kB | Preview Download |
Additional details
Related works
- Is supplement to
- Journal article: 10.3389/fcell.2020.00732 (DOI)